COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE

Matthieu Allez  ¹     Nassim Hammoudi  ²     Sofia Brand  ³     Stephane NANCEY  ⁴     Anthony Buisson  ⁵     Philippe Seksik  ⁶     Pauline Wils  ⁷     Arnaud Bourreille  ⁸     Xavier Treton  ⁹     Edouard Louis  ¹⁰     Guillaume Pineton de Chambrun  ¹¹     Mathurin Fumery  ¹²     Xavier Hebuterne  ¹³     Laurent Peyrin-Biroulet  ¹⁴     Franck Carbonnel  ¹⁵     Mélanie Serrero  ¹⁶     Madeleine Bezault  ¹⁷     Jérôme Lambert    
¹ Hopital Saint-Louis APHP, Université Denis Diderot Paris 7, Paris, France
² Hôpital Saint-Louis, Paris, France
³ Hôpital Saint Louis, Paris, France
⁴ Lyon, Pierre Benite, France
⁵ CHU Estaing Clermont-Ferrand, Clermont-ferrand, France
⁶ Gastroenterology and Nutrition Unit, Paris, France
⁷ CHRU Lille, Lille Cedex, France
⁸ Hopital Hotel Dieu et HME - HGE Aile Sud, Nantes Cedex 1, France
⁹ Hopital Beaujon, Asnieres, France
¹⁰ CHU Liège and Liège University, Liège, Belgium
¹¹ Montpellier, Montpellier, France
¹² Amiens University Hospital, Amiens, France
¹³ Hospital Archet 2, Nice, France
¹⁴ Nancy University Hospital, Vandoeuvre-les-Nancy, France
¹⁵ CHU Bicetre, Le Kremlin Bicetre, France
¹⁶ Hopital Nord, Marseille, France
¹⁷ REMIND, Paris, France

Topic
Endoscopy, IBD, Surgery

Session
The road towards eliminating recurrence in Crohn's disease

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)